Jafron Other Operating Expenses vs Total Operating Expenses Analysis

300529 Stock   25.73  0.54  2.06%   
Jafron Biomedical financial indicator trend analysis is infinitely more than just investigating Jafron Biomedical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Jafron Biomedical is a good investment. Please check the relationship between Jafron Biomedical Other Operating Expenses and its Total Operating Expenses accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Jafron Biomedical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Other Operating Expenses vs Total Operating Expenses

Other Operating Expenses vs Total Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Jafron Biomedical Other Operating Expenses account and Total Operating Expenses. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Jafron Biomedical's Other Operating Expenses and Total Operating Expenses is 0.93. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Total Operating Expenses in the same time period over historical financial statements of Jafron Biomedical Co, assuming nothing else is changed. The correlation between historical values of Jafron Biomedical's Other Operating Expenses and Total Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of Jafron Biomedical Co are associated (or correlated) with its Total Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Operating Expenses has no effect on the direction of Other Operating Expenses i.e., Jafron Biomedical's Other Operating Expenses and Total Operating Expenses go up and down completely randomly.

Correlation Coefficient

0.93
Relationship DirectionPositive 
Relationship StrengthVery Strong

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Jafron Biomedical. It is also known as Jafron Biomedical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Most indicators from Jafron Biomedical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Jafron Biomedical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Jafron Biomedical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
The current year's Tax Provision is expected to grow to about 119.8 M, whereas Selling General Administrative is forecasted to decline to about 312.9 M.
 2022 2023 2024 2025 (projected)
Operating Income1.0B523.2M601.6M528.6M
Total Revenue2.5B1.9B2.2B1.2B

Jafron Biomedical fundamental ratios Correlations

-0.150.970.980.980.980.961.00.980.610.960.510.960.980.950.990.480.90.970.930.930.860.80.930.730.93
-0.15-0.240.02-0.17-0.02-0.36-0.13-0.050.47-0.380.42-0.36-0.08-0.02-0.110.60.06-0.24-0.06-0.170.250.38-0.41-0.35-0.25
0.97-0.240.910.940.90.990.970.950.430.980.310.980.920.890.940.330.820.930.870.890.780.750.950.790.88
0.980.020.910.950.990.890.970.960.750.890.640.870.970.960.980.630.940.940.940.910.90.850.830.630.9
0.98-0.170.940.950.950.940.970.970.610.950.480.950.950.930.980.440.870.960.910.910.860.750.940.710.92
0.98-0.020.90.990.950.890.970.960.720.890.670.890.990.940.990.610.940.970.940.920.890.830.860.640.92
0.96-0.360.990.890.940.890.960.920.40.990.30.980.910.880.930.270.80.930.860.890.730.680.960.780.89
1.0-0.130.970.970.970.970.960.980.590.960.480.960.970.940.980.460.890.960.930.920.850.80.930.740.91
0.98-0.050.950.960.970.960.920.980.640.930.510.940.950.90.970.520.890.950.930.920.920.840.910.690.91
0.610.470.430.750.610.720.40.590.640.390.840.370.640.680.660.890.730.570.660.570.820.720.330.10.55
0.96-0.380.980.890.950.890.990.960.930.390.30.990.920.870.940.260.80.950.870.890.730.660.980.790.91
0.510.420.310.640.480.670.30.480.510.840.30.290.630.620.590.790.650.550.560.510.630.570.270.090.5
0.96-0.360.980.870.950.890.980.960.940.370.990.290.910.850.930.230.780.950.860.880.740.650.990.80.9
0.98-0.080.920.970.950.990.910.970.950.640.920.630.910.950.990.550.910.970.920.920.850.80.880.690.92
0.95-0.020.890.960.930.940.880.940.90.680.870.620.850.950.960.530.880.90.890.860.810.780.820.640.86
0.99-0.110.940.980.980.990.930.980.970.660.940.590.930.990.960.520.920.980.930.930.860.790.90.690.93
0.480.60.330.630.440.610.270.460.520.890.260.790.230.550.530.520.590.430.490.430.70.70.170.040.37
0.90.060.820.940.870.940.80.890.890.730.80.650.780.910.880.920.590.880.990.960.890.890.750.550.94
0.97-0.240.930.940.960.970.930.960.950.570.950.550.950.970.90.980.430.880.910.930.810.720.940.710.95
0.93-0.060.870.940.910.940.860.930.930.660.870.560.860.920.890.930.490.990.910.980.890.850.830.610.97
0.93-0.170.890.910.910.920.890.920.920.570.890.510.880.920.860.930.430.960.930.980.850.810.860.650.99
0.860.250.780.90.860.890.730.850.920.820.730.630.740.850.810.860.70.890.810.890.850.90.710.460.82
0.80.380.750.850.750.830.680.80.840.720.660.570.650.80.780.790.70.890.720.850.810.90.590.510.75
0.93-0.410.950.830.940.860.960.930.910.330.980.270.990.880.820.90.170.750.940.830.860.710.590.80.89
0.73-0.350.790.630.710.640.780.740.690.10.790.090.80.690.640.690.040.550.710.610.650.460.510.80.67
0.93-0.250.880.90.920.920.890.910.910.550.910.50.90.920.860.930.370.940.950.970.990.820.750.890.67
Click cells to compare fundamentals

Jafron Biomedical Account Relationship Matchups

Jafron Biomedical fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets3.2B4.8B5.4B5.5B6.4B6.7B
Other Current Liab140.8M129.3M5.5M4.9M5.6M5.3M
Total Current Liabilities330.8M386.3M717.2M829.4M953.8M1.0B
Total Stockholder Equity2.8B3.4B3.6B3.1B3.6B3.8B
Other Liab51.1M61.5M52.2M125.8M144.7M151.9M
Retained Earnings1.7B2.3B2.1B2.0B2.3B2.4B
Accounts Payable50.2M60.8M128.5M135.6M156.0M163.8M
Cash1.6B2.3B2.6B2.8B3.2B3.4B
Other Assets107.9M102.4M91.6M225.4M259.2M272.2M
Net Receivables167.4M269.1M221.7M74.9M86.1M115.1M
Inventory120.7M196.5M349.1M385.0M442.7M464.9M
Other Current Assets65.3M75.3M35.6M17.3M19.8M26.1M
Total Liab383.1M1.4B1.8B2.4B2.7B2.9B
Intangible Assets89.9M101.3M100.4M100.4M115.4M121.2M
Common Stock417.3M418.7M799.1M805.5M926.3M972.6M
Property Plant Equipment457.6M639.6M905.5M1.3B1.5B1.5B
Net Tangible Assets1.6B2.1B2.7B3.2B3.7B2.0B
Deferred Long Term Liab3.4M14.8M20.4M36.0M41.3M43.4M
Total Current Assets2.0B3.1B3.3B3.3B3.8B2.1B
Non Current Assets Total1.2B1.8B2.1B2.2B2.6B1.3B
Non Currrent Assets Other58.2M162.8M148.2M107.0M123.0M102.3M
Non Current Liabilities Total52.2M1.0B1.1B1.6B1.8B1.9B
Common Stock Shares Outstanding799.1M805.5M807.7M807.6M928.7M880.0M
Net Invested Capital2.8B4.3B4.8B4.8B5.5B3.4B
Net Working Capital1.7B2.7B2.6B2.5B2.9B2.0B
Capital Stock799.1M805.5M807.7M807.6M928.7M743.6M
Property Plant And Equipment Net905.5M1.3B1.7B1.8B2.0B1.4B
Property Plant And Equipment Gross1.0B1.4B1.9B2.1B2.4B1.6B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Jafron Stock

Balance Sheet is a snapshot of the financial position of Jafron Biomedical at a specified time, usually calculated after every quarter, six months, or one year. Jafron Biomedical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Jafron Biomedical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Jafron currently owns. An asset can also be divided into two categories, current and non-current.